NLP
HIMSS24
Dr. Tim O'Connell, cofounder and CEO of Emtelligent, believes healthcare organizations should not rely solely on AI for business processes and must train models on data sets that represent "all of humanity."
Prior to ChatGPT, modern medicine was slow to implement AI technologies, says Dr. Tim O'Connell, founder and CEO of medical natural language processing company emtelligent. Now, advances in accuracy are bringing the tech to the forefront.
HIMSS23
Calum Yacoubian, director of healthcare strategy at IQVIA, outlines natural language processing use cases, such as aggregating data for population health initiatives and supporting rare disease diagnoses for precision medicine.
HIMSS23
Tim O'Connell, CEO and founder of Emtelligent, talks about Emtelligent's NLP software, which is specially designed to understand medical English, and how it can assist drug companies with finding clinical trial cohorts from patient records.
HIMSS23
Natural language processing technology helps NorthShore University HealthSystem look at social determinants of health data. Health equity senior programmer analyst Emily Kwan highlights her upcoming HIMSS23 session.
Owensboro Health CMIO Dr. David Danhauer describes how he devised a safety initiative that integrated NLP with EHR work queues – helping review and track clinical notes to ensure radiology reports are capturing incidental findings.